INTERCEPT PHARMACEUTICALS, INC.
Pharmaceutical Preparations · 305 MADISON AVENUE, MORRISTOWN, NJ 07960
官方登記資料
0位追蹤者
2002成立於
關於 INTERCEPT PHARMACEUTICALS, INC.
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease, cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.
Source: Wikipedia
產業Pharmaceutical Preparations
總部305 MADISON AVENUE, MORRISTOWN, NJ 07960
成立時間2002
法律形式C Corporation
狀態營運中
專利253 項專利
COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USEUS20260000682A1 · 2026
METHODS FOR AMELIORATING COGNITIVE IMPAIRMENT USING BILE ACID DERIVATIVESUS2025375459A1 · 2025
關鍵數據
法律資訊
| 法定名稱 | INTERCEPT PHARMACEUTICALS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1270073在 SEC EDGAR 上查看 ↗ |
| EIN | 22-3868459 |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 305 MADISON AVENUE, MORRISTOWN, NJ 07960 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日